- Home
- KROS vs OLP Comparison
KROS vs OLP Comparison
Compare KROS & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | OLP |
|---|---|---|
| Founded | 2015 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 655.9M | 478.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | KROS | OLP |
|---|---|---|
| Price | $20.69 | $20.27 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $22.20 | N/A |
| AVG Volume (30 Days) | ★ 790.2K | 107.5K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 8.92% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.57 | 1.54 |
| Revenue | ★ $246,718,000.00 | $97,423,000.00 |
| Revenue This Year | $6,924.79 | $7.95 |
| Revenue Next Year | N/A | $6.06 |
| P/E Ratio | $13.35 | ★ $13.12 |
| Revenue Growth | ★ 37798.31 | 9.29 |
| 52 Week Low | $9.12 | $19.62 |
| 52 Week High | $22.55 | $28.36 |
Technical Indicators
Market Signals| Indicator | KROS | OLP |
|---|---|---|
| Relative Strength Index (RSI) | 57.59 | 44.19 |
| Support Level | $19.76 | $19.86 |
| Resistance Level | $21.76 | $21.66 |
| Average True Range (ATR) | 0.76 | 0.36 |
| MACD | -0.17 | -0.09 |
| Stochastic Oscillator | 37.70 | 23.32 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.